Medication for management of pregnancy-induced hypertension
Por um escritor misterioso
Descrição
Hypertension refers to increased arterial blood pressure and can be divided into two categories: primary and secondary. Primary hypertension caused by angiogenic degenerative changes is a degenerative disease. With liberalization of China’s reproduction policy and increases in maternal age, the prevalence of pregnancy-induced hypertension (PIH) in China has increased gradually. PIH is not a type of primary hypertension, but there are differences in the treatment of these two types of hypertension. Here, we review the choice and use of drugs for PIH management using drugs for the management of primary hypertension as a reference. First-line drugs such as labetalol, nifedipine, or methyldopa should be taken via the oral route if blood pressure is ≥ 150/90 mmHg. For chronic hypertension, other drugs should be added after the first drug at the highest concentration has been revealed to be ineffective. If the blood pressure of patients with acute hypertension is ≥ 160/110 mmHg, maternal stroke or eclampsia can result. If PIH patients are about to deliver, they can be given labetalol (i.v.), hydralazine (i.v.) or nifedipine (p.o.). Moreover, all anti-hypertensive treatments should be based on considerations of maternal and fetal safety.
Guidelines for diagnosis and treatment of hypertensive disorders of
Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets - The Lancet Diabetes & Endocrinology
Treatment for Mild Chronic Hypertension during Pregnancy
Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy
Best Practices for Managing Postpartum Hypertension
Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association
HYPERTENSIVE DISEASE IN PREGNANCY
Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance
Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance
Pregnancy-Induced Hypertension
Hypertension Canada's 2018 Guidelines for the Management of Hypertension in Pregnancy - Canadian Journal of Cardiology
de
por adulto (o preço varia de acordo com o tamanho do grupo)